Biofield Up 76 Percent
Share prices for the Biofield Corp. (OTCBB: BZET) jumped an additional 76.4 percent this morning after rising 40 percent yesterday afternoon, following the recent announcement of its master license agreement with MacKay Group Limited. According to the statement, this agreement grants the MacKay Group an "exclusive, sublicensable royalty-bearing license" to distribute, manufacture, develop and commercialize Biofield's breast cancer technology on the worldwide market. In return, the MacKay Group will pay Biofield a number of royalties based on the gross receipts received by MacKay Group and its affiliates, along with a payment of $1 million for licensing fees. This could be…